The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global Epigenetic market was valued at US$ 6761.2 million in 2023 and is anticipated to reach US$ 11500 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
This report aims to provide a comprehensive presentation of the global market for Epigenetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenetic.
Report Scope
The Epigenetic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epigenetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epigenetic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
Segment by Type
Reagents
Kits
Instruments
Enzymes
Services
Segment by Application
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenetic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global Epigenetic market was valued at US$ 6761.2 million in 2023 and is anticipated to reach US$ 11500 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
This report aims to provide a comprehensive presentation of the global market for Epigenetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenetic.
Report Scope
The Epigenetic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epigenetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epigenetic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
Segment by Type
Reagents
Kits
Instruments
Enzymes
Services
Segment by Application
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenetic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Reagents
1.2.3 Kits
1.2.4 Instruments
1.2.5 Enzymes
1.2.6 Services
1.3 Market by Application
1.3.1 Global Epigenetic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic Research Institutes
1.3.3 Biotechnology Companies
1.3.4 Biopharmaceutical Companies
1.3.5 Diagnostic Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epigenetic Market Perspective (2019-2030)
2.2 Epigenetic Growth Trends by Region
2.2.1 Global Epigenetic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Epigenetic Historic Market Size by Region (2019-2024)
2.2.3 Epigenetic Forecasted Market Size by Region (2025-2030)
2.3 Epigenetic Market Dynamics
2.3.1 Epigenetic Industry Trends
2.3.2 Epigenetic Market Drivers
2.3.3 Epigenetic Market Challenges
2.3.4 Epigenetic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epigenetic Players by Revenue
3.1.1 Global Top Epigenetic Players by Revenue (2019-2024)
3.1.2 Global Epigenetic Revenue Market Share by Players (2019-2024)
3.2 Global Epigenetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Epigenetic Revenue
3.4 Global Epigenetic Market Concentration Ratio
3.4.1 Global Epigenetic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetic Revenue in 2023
3.5 Epigenetic Key Players Head office and Area Served
3.6 Key Players Epigenetic Product Solution and Service
3.7 Date of Enter into Epigenetic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenetic Breakdown Data by Type
4.1 Global Epigenetic Historic Market Size by Type (2019-2024)
4.2 Global Epigenetic Forecasted Market Size by Type (2025-2030)
5 Epigenetic Breakdown Data by Application
5.1 Global Epigenetic Historic Market Size by Application (2019-2024)
5.2 Global Epigenetic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Epigenetic Market Size (2019-2030)
6.2 North America Epigenetic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Epigenetic Market Size by Country (2019-2024)
6.4 North America Epigenetic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Epigenetic Market Size (2019-2030)
7.2 Europe Epigenetic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Epigenetic Market Size by Country (2019-2024)
7.4 Europe Epigenetic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Epigenetic Market Size (2019-2030)
8.2 Asia-Pacific Epigenetic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Epigenetic Market Size by Region (2019-2024)
8.4 Asia-Pacific Epigenetic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Epigenetic Market Size (2019-2030)
9.2 Latin America Epigenetic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Epigenetic Market Size by Country (2019-2024)
9.4 Latin America Epigenetic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epigenetic Market Size (2019-2030)
10.2 Middle East & Africa Epigenetic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Epigenetic Market Size by Country (2019-2024)
10.4 Middle East & Africa Epigenetic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Epigenetic Introduction
11.1.4 Illumina Revenue in Epigenetic Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Epigenetic Introduction
11.2.4 Qiagen Revenue in Epigenetic Business (2019-2024)
11.2.5 Qiagen Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Epigenetic Introduction
11.3.4 Abcam Revenue in Epigenetic Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Detail
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Epigenetic Introduction
11.4.4 Merck & Co Revenue in Epigenetic Business (2019-2024)
11.4.5 Merck & Co Recent Development
11.5 Sigma-Aldrich
11.5.1 Sigma-Aldrich Company Detail
11.5.2 Sigma-Aldrich Business Overview
11.5.3 Sigma-Aldrich Epigenetic Introduction
11.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2019-2024)
11.5.5 Sigma-Aldrich Recent Development
11.6 New England Biolabs
11.6.1 New England Biolabs Company Detail
11.6.2 New England Biolabs Business Overview
11.6.3 New England Biolabs Epigenetic Introduction
11.6.4 New England Biolabs Revenue in Epigenetic Business (2019-2024)
11.6.5 New England Biolabs Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Detail
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Epigenetic Introduction
11.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2019-2024)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Diagenode
11.8.1 Diagenode Company Detail
11.8.2 Diagenode Business Overview
11.8.3 Diagenode Epigenetic Introduction
11.8.4 Diagenode Revenue in Epigenetic Business (2019-2024)
11.8.5 Diagenode Recent Development
11.9 Active Motif
11.9.1 Active Motif Company Detail
11.9.2 Active Motif Business Overview
11.9.3 Active Motif Epigenetic Introduction
11.9.4 Active Motif Revenue in Epigenetic Business (2019-2024)
11.9.5 Active Motif Recent Development
11.10 Roche Diagnostics
11.10.1 Roche Diagnostics Company Detail
11.10.2 Roche Diagnostics Business Overview
11.10.3 Roche Diagnostics Epigenetic Introduction
11.10.4 Roche Diagnostics Revenue in Epigenetic Business (2019-2024)
11.10.5 Roche Diagnostics Recent Development
11.11 Eisai
11.11.1 Eisai Company Detail
11.11.2 Eisai Business Overview
11.11.3 Eisai Epigenetic Introduction
11.11.4 Eisai Revenue in Epigenetic Business (2019-2024)
11.11.5 Eisai Recent Development
11.12 Novartis
11.12.1 Novartis Company Detail
11.12.2 Novartis Business Overview
11.12.3 Novartis Epigenetic Introduction
11.12.4 Novartis Revenue in Epigenetic Business (2019-2024)
11.12.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
